Nicorandil and Leukocyte Activation

Nicorandil, a hybrid compound of an ATP-sensitive potassium (KATP) channel opener and a nitric oxide donor, has been reported to preserve microvascular integrity in patients with reperfused myocardial infarction. The aim of the current study was to test the hypothesis that nicorandil suppresses activation of polymorphonuclear leukocytes (PMNLs), resulting in reduction of PMNL migration into tissue upon ischemia/reperfusion. Nicorandil, along with the mitochondrial KATP channel opener diazoxide and the nitric oxide donors nitroglycerin and isosorbide dinitrate, suppressed pseudopod projection in human PMNLs treated with 10−9M N-formyl-methionyl-leucyl-phenylalanine (FMLP) and subjected to shear stress (5 dyn/cm2) with a cone-and-plate shear device. Suppression by nicorandil and diazoxide was reversed by KATP channel blockers, 5 hydroxydecanoate and glibenclamide. FMLP-induced increase of [Ca2+]in in PMNLs was suppressed by nicorandil and diazoxide, and 5 hydroxy-decanoate and glibenclamide reversed this suppression. Results of reverse transcription polymerase chain reaction with rat PMNL mRNA indicated the presence of mRNAs of Kir6.2 and Kir6.1 but not mRNAs of sulfonylurea receptor 1 or 2. Isosorbide dinitrate, diazoxide, and nicorandil reduced leukocyte migration and microvascular obstruction in reperfused ischemic tissue of rat mesenteric microcirculation. In conclusion, nicorandil attenuates ischemia/reperfusion-induced PMNL activation via donation of nitric oxide and K channel–related cascade.

[1]  G. Gross,et al.  Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil , 1992, Cardiovascular Drugs and Therapy.

[2]  S. Seino,et al.  Role of sarcolemmal KATP channels in cardioprotection against ischemia/reperfusion injury in mice , 2002 .

[3]  C. Kramer,et al.  Hypereosinophilic syndrome and restrictive cardiomyopathy due to apical thrombi. , 2001, Circulation.

[4]  Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management , 2001, Heart.

[5]  P. Vallance,et al.  Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. , 2001, Circulation.

[6]  E. Marbán,et al.  Nicorandil , 2024, Reactions Weekly.

[7]  G. Schmid-Schönbein,et al.  Mechanisms for regulation of fluid shear stress response in circulating leukocytes. , 2000, Circulation research.

[8]  E. Moilanen,et al.  Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. , 1999, European journal of pharmacology.

[9]  G. Schmid-Schönbein,et al.  Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: microvascular mechanisms for persistent tissue echo enhancement. , 1999, Journal of the American College of Cardiology.

[10]  YigangWang,et al.  Role of Protein Kinase C in Mitochondrial KATP Channel–Mediated Protection Against Ca2+ Overload Injury in Rat Myocardium , 1999 .

[11]  M. Ashraf,et al.  Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium. , 1999, Circulation research.

[12]  Y. Taniyama,et al.  Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. , 1999, Journal of the American College of Cardiology.

[13]  M. Hallett,et al.  Ca2+ signalling delays in neutrophils: effects of prior exposure to platelet activating factor or formyl-met-leu-phe. , 1998, Cellular signalling.

[14]  M. Horie,et al.  Myocardial ischemia induces differential regulation of KATP channel gene expression in rat hearts. , 1997, The Journal of clinical investigation.

[15]  M. Smith,et al.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.

[16]  G. Schmid-Schönbein,et al.  The leukocyte response to fluid stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. L. Le Beau,et al.  Cloning, Tissue Expression, and Chromosomal Localization of SUR2, the Putative Drug-Binding Subunit of Cardiac, Skeletal Muscle, and Vascular KATP Channels , 1996, Diabetes.

[18]  V. Yarov-Yarovoy,et al.  The Mitochondrial K Channel as a Receptor for Potassium Channel Openers (*) , 1996, The Journal of Biological Chemistry.

[19]  K. Shirato,et al.  Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. , 1995, Journal of cardiovascular pharmacology.

[20]  G. Gross,et al.  Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. , 1995, Circulation.

[21]  S. Abramson,et al.  Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils , 1995, Journal of leukocyte biology.

[22]  G. Gross,et al.  Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. , 1995, Cardiovascular research.

[23]  G. Schmid-Schönbein,et al.  Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[24]  F. Sendo,et al.  Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. II. Inhibition by RP-3 treatment of mononuclear leukocyte recruitment in delayed-type hypersensitivity to sheep red blood cells in rats. , 1993, Journal of immunology.

[25]  A. M. Lefer,et al.  Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. , 1992, The American journal of physiology.

[26]  G. Gross,et al.  EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes. , 1992, Immunopharmacology.

[27]  A. M. Lefer,et al.  Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. , 1990, Circulation.

[28]  K. Mullane,et al.  Polymorphonuclear leukocytes reduce cardiac function in vitro by release of H2O2. , 1990, The American journal of physiology.

[29]  J. Covell,et al.  Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. , 1987, Circulation research.

[30]  L. Horwitz,et al.  Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. , 1987, The Journal of clinical investigation.

[31]  A. Noma,et al.  ATP-regulated K+ channels in cardiac muscle , 1983, Nature.

[32]  R. Skalak,et al.  Human Leukocytes in the Active State , 1982 .